These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27500408)

  • 1. Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol.
    Fonoudi H; Ansari H; Abbasalizadeh S; Blue GM; Aghdami N; Winlaw DS; Harvey RP; Bosman A; Baharvand H
    J Vis Exp; 2016 Jul; (113):. PubMed ID: 27500408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells.
    Chen VC; Ye J; Shukla P; Hua G; Chen D; Lin Z; Liu JC; Chai J; Gold J; Wu J; Hsu D; Couture LA
    Stem Cell Res; 2015 Sep; 15(2):365-75. PubMed ID: 26318718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac differentiation of human pluripotent stem cells in scalable suspension culture.
    Kempf H; Kropp C; Olmer R; Martin U; Zweigerdt R
    Nat Protoc; 2015 Sep; 10(9):1345-61. PubMed ID: 26270394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale production of human pluripotent stem cell derived cardiomyocytes.
    Kempf H; Andree B; Zweigerdt R
    Adv Drug Deliv Rev; 2016 Jan; 96():18-30. PubMed ID: 26658242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
    Talkhabi M; Aghdami N; Baharvand H
    Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust Generation of Cardiomyocytes from Human iPS Cells Requires Precise Modulation of BMP and WNT Signaling.
    Kadari A; Mekala S; Wagner N; Malan D; Köth J; Doll K; Stappert L; Eckert D; Peitz M; Matthes J; Sasse P; Herzig S; Brüstle O; Ergün S; Edenhofer F
    Stem Cell Rev Rep; 2015 Aug; 11(4):560-9. PubMed ID: 25392050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of Cardiomyocytes from Human Pluripotent Stem Cells by Bioreactor Technologies.
    Halloin C; Coffee M; Manstein F; Zweigerdt R
    Methods Mol Biol; 2019; 1994():55-70. PubMed ID: 31124104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.
    van den Heuvel NH; van Veen TA; Lim B; Jonsson MK
    J Mol Cell Cardiol; 2014 Feb; 67():12-25. PubMed ID: 24370890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells.
    Pei F; Jiang J; Bai S; Cao H; Tian L; Zhao Y; Yang C; Dong H; Ma Y
    Stem Cell Res; 2017 Mar; 19():94-103. PubMed ID: 28110125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of functional murine cardiac myocytes from induced pluripotent stem cells.
    Mauritz C; Schwanke K; Reppel M; Neef S; Katsirntaki K; Maier LS; Nguemo F; Menke S; Haustein M; Hescheler J; Hasenfuss G; Martin U
    Circulation; 2008 Jul; 118(5):507-17. PubMed ID: 18625890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of small molecule-induced cardiomyocytes from human induced pluripotent stem cells using a reporter system.
    Hwang GH; Park SM; Han HJ; Kim JS; Yun SP; Ryu JM; Lee HJ; Chang W; Lee SJ; Choi JH; Choi JS; Lee MY
    J Cell Physiol; 2017 Dec; 232(12):3384-3395. PubMed ID: 28063225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous WNT Control Enables Advanced hPSC Cardiac Processing and Prognostic Surface Marker Identification in Chemically Defined Suspension Culture.
    Halloin C; Schwanke K; Löbel W; Franke A; Szepes M; Biswanath S; Wunderlich S; Merkert S; Weber N; Osten F; de la Roche J; Polten F; Christoph Wollert K; Kraft T; Fischer M; Martin U; Gruh I; Kempf H; Zweigerdt R
    Stem Cell Reports; 2019 Aug; 13(2):366-379. PubMed ID: 31353227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of Cardiomyocytes from Human Pluripotent Stem Cells in Fully Chemically Defined Conditions.
    Lin Y; Zou J
    STAR Protoc; 2020 Jun; 1(1):. PubMed ID: 32734277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling.
    Lian X; Hsiao C; Wilson G; Zhu K; Hazeltine LB; Azarin SM; Raval KK; Zhang J; Kamp TJ; Palecek SP
    Proc Natl Acad Sci U S A; 2012 Jul; 109(27):E1848-57. PubMed ID: 22645348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
    Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
    Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions.
    van den Berg CW; Elliott DA; Braam SR; Mummery CL; Davis RP
    Methods Mol Biol; 2016; 1353():163-80. PubMed ID: 25626427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardized production of hPSC-derived cardiomyocyte aggregates in stirred spinner flasks.
    Kriedemann N; Triebert W; Teske J; Mertens M; Franke A; Ullmann K; Manstein F; Drakhlis L; Haase A; Halloin C; Martin U; Zweigerdt R
    Nat Protoc; 2024 Jul; 19(7):1911-1939. PubMed ID: 38548938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor.
    Niebruegge S; Bauwens CL; Peerani R; Thavandiran N; Masse S; Sevaptisidis E; Nanthakumar K; Woodhouse K; Husain M; Kumacheva E; Zandstra PW
    Biotechnol Bioeng; 2009 Feb; 102(2):493-507. PubMed ID: 18767184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling.
    Abilez OJ; Tzatzalos E; Yang H; Zhao MT; Jung G; Zöllner AM; Tiburcy M; Riegler J; Matsa E; Shukla P; Zhuge Y; Chour T; Chen VC; Burridge PW; Karakikes I; Kuhl E; Bernstein D; Couture LA; Gold JD; Zimmermann WH; Wu JC
    Stem Cells; 2018 Feb; 36(2):265-277. PubMed ID: 29086457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.